USMLE Prep - Medical Reference Library

Diabetic Ketoacidosis — Adult ED Management

System: Endocrinology • Reviewed: Aug 31, 2025 • Step 1Step 2Step 3

Synopsis:

Fluid resuscitation, insulin infusion with careful potassium management, and identification of precipitating cause; transition to subcutaneous insulin after resolution criteria met.

Key Points

  • Stabilize ABCs; begin targeted evaluation without delaying life-saving therapy.
  • Use system-specific risk tools to guide testing and disposition.
  • Order high-yield tests first; escalate imaging when indicated.
  • Start evidence-based initial therapy and reassess frequently.

Algorithm

  1. Primary survey and vitals; IV access and monitors.
  2. Focused history/physical; identify red flags and likely etiologies.
  3. Order system-appropriate labs and imaging (see Investigations).
  4. Initiate guideline-based empiric therapy (see Pharmacology).
  5. Reassess response; arrange consultation and definitive management.

Clinical Synopsis & Reasoning

DKA is precipitated by insulin deficiency and counter‑regulatory surge, producing hyperglycemia, ketonemia, and anion‑gap acidosis. Confirm diagnosis with glucose, β‑hydroxybutyrate/ketones, pH, and bicarbonate; assess volume depletion and precipitating factors (infection, insulin omission, MI, stroke). Expect total body potassium deficit despite initial normal/elevated K⁺. Frequent bedside reassessment and point‑of‑care tests are critical to guide safe correction and detect cerebral edema risk.


Treatment Strategy & Disposition

Resuscitate with balanced crystalloids, begin insulin infusion after verifying K⁺ ≥3.3 mEq/L, and replace electrolytes proactively, especially potassium and phosphate as indicated. Once glucose reaches ~200–250 mg/dL with persistent ketosis, add dextrose to avoid hypoglycemia while clearing ketones; transition to basal‑bolus when anion gap closes and patient can eat. Treat precipitants (e.g., antibiotics for infection) and provide sick‑day education. ICU admission for severe acidosis, altered mental status, or need for continuous insulin/electrolyte titration; otherwise step‑down with protocolized monitoring.


Epidemiology / Risk Factors

  • Diabetes and endocrine disorders depending on topic

Investigations

TestRole / RationaleTypical FindingsNotes
BMPElectrolytes/anion gapDerangements
Ketones (if DKA)KetoacidosisPositive
ABG/VBGAcid–base statusAcidosis/alkalosis

Key Numbers

ParameterTarget
Potassium before insulin≥3.3 mEq L
Glucose fall rate50 to 75 mg dL per hour
ResolutionNormal anion gap and ketones cleared

Pharmacology

MedicationMechanismOnsetRole in TherapyLimitations
Regular insulin (IV)Anabolic/anti-ketoticMinutesCorrect hyperglycemia/ketosisHypoglycemia, hypokalemia
Phosphate (select cases)Electrolyte repletionHoursSevere depletionHypocalcemia
Potassium chlorideElectrolyte repletionHoursPrevent hypokalemiaOvercorrection arrhythmia
Sodium bicarbonateBufferHoursSevere acidemia (pH ≤6.9)Alkalemia, hypokalemia
Isotonic fluidsVolume expansionImmediateRestore perfusion and osmolar balanceFluid overload in CHF/CKD

Prognosis / Complications

  • Improves with derangement correction; recurrence if triggers persist

Patient Education / Counseling

  • Explain red flags and when to seek emergent care.
  • Reinforce medication adherence and follow-up plan.

Notes

Use beta hydroxybutyrate when available. Avoid routine bicarbonate unless severe acidemia.


References

  1. ADA Standards of Care — DKA — Link
  2. Endocrine Society — Hyperglycemic Crises — Link